Chairpersons' Recap and Welcome

Peter Kramer, PhD, Senior Director, External Science, Technology & Licensing, BRISTOL-MYERS SQUIBB
Vik Seoni, Vice President, Business Development, ENDO PHARMACEUTICALS

Drug Delivery Partnerships Trend Report 2007 - What' s Fueling Market Changes?

Roger Longman, Managing Partner, WINDHOVER INFORMATION

Ultimately, What are the Unique Needs of the End User? – A Patient's Perspective on the Use of Drug Delivery with Hamilton Jordan

Hamilton Jordan, White House Chief of Staff, President Carter, Bestselling Author, No Such Thing As a Bad Day

How the End-User Can Inspire New Opportunities: Bridging the Patient, Physician and Payer

Moderator:
Hamilton Jordan, Bestselling Author of "No Such Thing As a Bad Day", former WHITE HOUSE Chief of Staff under President Carter and Co-Founder of UNITY 08

Panelists:
Patty Neurohr, Director, Clinical Program Management, HIGHMARK BLUE CROSS BLUE SHIELD

Cornell Stamoran, VP Strategic Intelligence & Planning, CARDINAL HEALTH

Strategically Position Your Product for Optimal Candidacy for Reimbursement & Pricing

Cynthia Tudor, Director, Medicare Drug Benefit Group, CENTERS FOR MEDICARE AND MEDICAID SERVICES

Darren Siversten, SVP of Operations, SIERRA HEALTH SERVICES

User-Centered Innovation in Drug Delivery and Adherence

Craig F. Sampson, Health Practice Lead, IDEO

Morning Re-Cap: What Does This All Mean for the Industry?

Cornell Stamoran, VP Strategic Intelligence & Planning, CARDINAL HEALTH

Track Chair:

Frank Grams, Global Head, Drug Delivery Partnering, ROCHE

Track Chair:

Sandy Eisen
Chief Medical Officer
TEVA EUROPE

Track Chair:

Franklin Okumu, PhD, Executive Director of Biopharmaceutical R&D, DURECT CORPORATION

2:15 | Exubera®: The Improbable but Successful Collaboration between Device (Nektar) and Pill (Pfizer) Companies

Robert P. Moran, President, PLEXUS VENTURES LLC

2:15 | Setting Priorities for Investment in Biotechnology Drug Delivery Systems: Which Projects are Right for My Brand?

Scott A. Siegel, PhD, Executive Director, New Business Development, ORTHO BIOTECH

2:15 | Drug Delivery Considerations in Emergency Preparedness

Jerome A Donlon, MD, PhD, Chief Scientist, DEPARTMENT OF HEALTH & HUMAN SERVICES

2:45 | Globalization of Drug Delivery: Assessing Business Opportunities in Southeast Asia to Expand International Market Share: WHO, WHAT, WHERE?

Moderator:
James Foley, Former VP, Business Development, BRISTOL MYERS-SQUIBB Chief Executive Officer, SMART BIOSCIENCES

Panelists:
Scott Kozak, VP, Commercial Operations, RHEI PHARMACEUTICALS

Wendy Pan, MORGAN LEWIS & BOCKIUS

2:45 | Integrate Enhanced Drug Delivery Options to Carve a Unique Place for Your Consumer & OTC Products

Moderator:
Bob Nissen, Consultant, Business Development, North America BAYER HEALTHCARE CONSUMER CARE DIVISION

Panelists:
Vincent Li, Technology Assessment, WYETH CONSUMER HEALTHCARE

Tim Saxon, Former Assistant Vice President, Global Business Development WYETH CONSUMER HEALTHCARE

Andrew Lee Shorter, Director R&D & Technical Licensing GLAXOSMITHKLINE

2:45 | The Challenge of Delivering Therapeutic siRNAs

Paul H. Johnson, PhD, Senior Vice President, of Research and Development and Chief Scientific Officer, NASTECH PHARMACEUTICAL COMPANY INC

3:15 | Making Better Drug Delivery-Enabled Program/Project Decisions

Moderator:
Jon Meyer, Associate Director, NAVIGANT CONSULTING INC

Panelists:
Tahir Mahmood, Lead Business Analyst, AMGEN

James Singell, Manager of New Product Planning for Drug Delivery Systems, ELI LILLY

Woody Bryan, Vice President, Business Development, SUPERNUS

3:15 | Today's Brands, Tomorrow's Generics: Understanding the Generic Business Model

Salah U. Ahmed, PhD, Senior VP, R&D, BARR LAB INC

Vijay P. Karwal, CFA, Executive Director, Healthcare Banking Group, ABN AMRO INCORPORATED

Donna French, PhD, Executive Director, Drug Delivery Engineering, AMGEN

3:45 | Selecting a Partner with Good Chemistry

Moderator:
Hans Christinger, Manager, Business Development, ABBOTT LABORATORIES

Panelists:
John Taylor, Director, Business Development, EURAND

Kendra Eager, Assistant Vice President, WYETH

Jim Stuart, Director, R&D Collaborations Management, CENTOCOR

3:45 | Solidify Your Competitive Advantage to Ward Off Generic Threat and Sustain Market Share

Balu Gupta, PhD, JD, Associate VP/Head CNS Group, US Patent Operations SANOFI-AVENTIS